Genmab A/S (ETR:GE9)
236.90
+1.00 (0.42%)
At close: Sep 19, 2025
Genmab Market Cap
Genmab has a market cap or net worth of €14.90 billion as of September 19, 2025. Its market cap has decreased by -6.38% in one year.
Market Cap
14.90B
Enterprise Value
12.56B
Revenue
3.11B
Ranking
n/a
PE Ratio
12.77
Stock Price
€236.90
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 14.90B, an increase of 2,969.31%. That is a compound annual growth rate of 14.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 14.90B | 17.18% |
Dec 30, 2024 | 12.72B | -32.67% |
Dec 29, 2023 | 18.89B | -26.92% |
Dec 30, 2022 | 25.84B | 11.67% |
Dec 30, 2021 | 23.14B | 6.90% |
Dec 30, 2020 | 21.65B | 67.74% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 267.28B |
Siemens Aktiengesellschaft | 176.90B |
Deutsche Telekom AG | 139.58B |
Allianz SE | 132.14B |
Rheinmetall AG | 88.07B |
Siemens Energy AG | 75.21B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.38B |
Deutsche Bank Aktiengesellschaft | 58.32B |